Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $9.8000 (0.2%) ($9.6100 - $9.9800) on Tue. Apr. 2, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.53% (three month average) | RSI | 39 | Latest Price | $9.8000(0.2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 0.5% a day on average for past five trading days. | Weekly Trend | IOVA declines -2.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(48%) ARKG(47%) IWO(43%) ARKK(41%) | Factors Impacting IOVA price | IOVA will decline at least -1.765% in a week (0% probabilities). VXX(-13%) VIXM(-8%) UUP(-7%) IFRA(-5%) TLT(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.765% (StdDev 3.53%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $1.62(-83.47%) | Resistance Level | $9.92 | 5 Day Moving Average | $9.59(2.19%) | 10 Day Moving Average | $9.68(1.24%) | 20 Day Moving Average | $9.92(-1.21%) | To recent high | -13% | To recent low | 16.5% | Market Cap | $1.435b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |